Clarivates Drugs to Watch 2026 report highlights Eli Lillys late-stage cardiometabolic candidates orforglipron and retatrutide as the clear standouts in an obesity and diabetes market projected to reach $150 billion by 2035
If you are pregnant or plan to become pregnant, please inform our team before starting the treatment
These symptoms have many potential causes, most of them benign, but investigation ensures nothing serious gets missed
It's worth taking a moment to explain how this works in more detail
However, clinical data and patient reports consistently show that symptom severity decreases as the body becomes accustomed to the medication
Ozempic (semaglutide) Ozempic is FDA-approved , along with diet and exercise, for controlling blood sugar in adults with type 2 diabetes and reducing cardiovascular risks such as stroke, heart attack, and death from cardiovascular issues in adults with type 2 diabetes and heart disease